In vivo dosimetry with an inorganic scintillation detector during multi-channel vaginal cylinder pulsed dose-rate brachytherapy: Dosimetry for pulsed dose-rate brachytherapy
Peter D. Georgi , Søren K. Nielsen , Anders T. Hansen , Harald Spejlborg , Susanne Rylander , Jacob Lindegaard , Simon Buus , Christian Wulff , Primoz Petric , Kari Tanderup , Jacob G. Johansen
{"title":"In vivo dosimetry with an inorganic scintillation detector during multi-channel vaginal cylinder pulsed dose-rate brachytherapy: Dosimetry for pulsed dose-rate brachytherapy","authors":"Peter D. Georgi , Søren K. Nielsen , Anders T. Hansen , Harald Spejlborg , Susanne Rylander , Jacob Lindegaard , Simon Buus , Christian Wulff , Primoz Petric , Kari Tanderup , Jacob G. Johansen","doi":"10.1016/j.phro.2024.100638","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and purpose</h3><p>In vivo dosimetry is not standard in brachytherapy and some errors go undetected. The aim of this study was to evaluate the accuracy of multi-channel vaginal cylinder pulsed dose-rate brachytherapy using in vivo dosimetry.</p></div><div><h3>Materials and methods</h3><p>In vivo dosimetry data was collected during the years 2019–2022 for 22 patients (32 fractions) receiving multi-channel cylinder pulsed dose-rate brachytherapy. An inorganic scintillation detector was inserted in a cylinder channel. Each fraction was analysed as independent data sets. In vivo dosimetry-based source-tracking was used to determine the relative source-to-detector position. Measured dose was compared to planned and re-calculated source-tracking based doses. Assuming no change in organ and applicator geometry throughout treatment, the planned and source-tracking based dose distributions were compared in select volumes via γ-index analysis and dose-volume-histograms.</p></div><div><h3>Results</h3><p>The mean ± SD planned vs. measured dose deviations in the first pulse were 0.8 <span><math><mrow><mo>±</mo></mrow></math></span> 5.9 %. In 31/32 fractions the deviation was within the combined in vivo dosimetry uncertainty (averaging 9.7 %, <em>k =</em> 2) and planning dose calculation uncertainty (1.6 %, <em>k =</em> 2). The dwell-position offsets were < 2 mm for 88 % of channels, with the largest being 5.1 mm (4.0 mm uncertainty, <em>k =</em> 2). 3 %/2 mm γ pass-rates averaged 97.0 % (clinical target volume (CTV)), 100.0 % (rectum), 99.9 % (bladder). The mean ± SD deviation was −1.<span><math><mrow><mn>1</mn></mrow></math></span> ± 2.9 % for CTV D98, and −0.2 ± 0.9 % and −1.2 ± 2.5 %, for bladder and rectum D2cm<sup>3</sup> respectively, indicating good agreement between intended and delivered dose.</p></div><div><h3>Conclusions</h3><p>In vivo dosimetry verified accurate and stable dose delivery in multi-channel vaginal cylinder based pulsed dose-rate brachytherapy.</p></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405631624001088/pdfft?md5=e582505d93f2167330a052ddaf354c3b&pid=1-s2.0-S2405631624001088-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics and Imaging in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405631624001088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose
In vivo dosimetry is not standard in brachytherapy and some errors go undetected. The aim of this study was to evaluate the accuracy of multi-channel vaginal cylinder pulsed dose-rate brachytherapy using in vivo dosimetry.
Materials and methods
In vivo dosimetry data was collected during the years 2019–2022 for 22 patients (32 fractions) receiving multi-channel cylinder pulsed dose-rate brachytherapy. An inorganic scintillation detector was inserted in a cylinder channel. Each fraction was analysed as independent data sets. In vivo dosimetry-based source-tracking was used to determine the relative source-to-detector position. Measured dose was compared to planned and re-calculated source-tracking based doses. Assuming no change in organ and applicator geometry throughout treatment, the planned and source-tracking based dose distributions were compared in select volumes via γ-index analysis and dose-volume-histograms.
Results
The mean ± SD planned vs. measured dose deviations in the first pulse were 0.8 5.9 %. In 31/32 fractions the deviation was within the combined in vivo dosimetry uncertainty (averaging 9.7 %, k = 2) and planning dose calculation uncertainty (1.6 %, k = 2). The dwell-position offsets were < 2 mm for 88 % of channels, with the largest being 5.1 mm (4.0 mm uncertainty, k = 2). 3 %/2 mm γ pass-rates averaged 97.0 % (clinical target volume (CTV)), 100.0 % (rectum), 99.9 % (bladder). The mean ± SD deviation was −1. ± 2.9 % for CTV D98, and −0.2 ± 0.9 % and −1.2 ± 2.5 %, for bladder and rectum D2cm3 respectively, indicating good agreement between intended and delivered dose.
Conclusions
In vivo dosimetry verified accurate and stable dose delivery in multi-channel vaginal cylinder based pulsed dose-rate brachytherapy.